🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Treatment Gaining Traction Via Social Media

Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these accounts directly for source information, while also obtaining promotional offers.

Active Commerce on Social Networks

Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share comparison photos, administration instructions and claims of next-day British shipping. Sellers market the drug there before directing buyers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Worries

However, physicians and chemists have warned that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could lead to users injecting substances of uncertain source.

Several professionals stated the demand for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer regulations, risking penalties, legal action or imprisonment.

Platform Response and Material Removal

According to the social media company, the platform has taken down problematic material and prohibited associated keywords and query recommendations. The company said it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Investigations also found communities with up to nine thousand participants marketing retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of users, populated with images of slimming results, positive reviews and step-by-step guides for preparing or administering at home.

After minutes of entering one community, a seller shared contact information, where the majority of purchases take place. The vendor provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or past usage.

Item Information and Costs

Within these communities, messages display dark colored packages with Royal Mail stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service stated it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering materials they can’t verify. Although the research behind retatrutide is valid, these online versions may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose patients to possibly serious health risks”.